As reported by KrAsia in April 2021, Indonesia-based health startup Halodoc has raised $80 million from Astra and Temasek. [indonesiabased halodoc 80m temasekasia]
Key Takeaways:
- Indonesian health tech firm Halodoc raised $80 million in a Series C funding round led by Astra in April 2021
- Temasek, Novo Holdings, TMI, and Bangkok Bank also participated in the round
- Halodoc plans to use the funds to expand its product suite and improve its app’s user interface
- The company has partnered with over 20,000 licensed doctors and 4,000 drug stores to provide home delivery services for medicines
- Halodoc actively participated in the COVID-19 response in Indonesia, partnered with the government to run vaccination centers across the country
Halodoc is an Indonesian health tech firm that facilitates millions of patients in Indonesia by connecting them with licensed doctors. At the time of the Covid-19 horrors, Halodoc was seen at the forefront against the battles of the pandemic. The company worked with the government-led task force and helped the Indonesian government and the people in tough times.
In a Series C round led by Astra, Halodoc has successfully raised $80 million in funding. Temasek, Novo Holdings, TMI (Telkomsel’s venture arm), and Bangkok Bank participated in the round. This new round happened after they raised about US$100 million from two other rounds in 2019 called the “series B” and “B+” rounds.
What’s notable about the year 2019 and Halodoc’s funding is that the health startups received funding from the Bill & Melinda Gates Foundation, which is a huge achievement for the Indonesia-based digital health company.
Along with the aforementioned investors, existing backers including Allianz X, Singtel Innov8, Openspace Ventures, UOB Venture Management, and Blibli also participated. [indonesiabased halodoc 80m temasekasia]
Halodoc Financial Profile
| Funding Round | Date | Lead Investor | Capital Raised |
| Series C | April 21, 2021 | PT. Astra International Tbk | $80 Million |
| Series B | July 25, 2019 | Allianz X | – |
| Series B | March 4, 2019 | UOB Venture | $65 Million |
| Series A | September 9, 2016 | Clermont Group | – |
Halodoc plans to utilize the fresh funding to expand its product suite and improve the current digital health services it offers. Also, the company plans to improve its app’s UI so that it becomes a better and easier experience for patients.
The health startup also helped the government in the battle against Covid-19. Haldoc would offer services such as in-site and drive-through tests, vaccinations, and health screenings. They also had an in-app symptom check-up system in their mobile application to detect symptoms and decide if the patient needed on-site services or not. [indonesiabased halodoc 80m temasekasia]
“We are proud to be at the forefront of Indonesia’s fight against COVID-19…The technology that powers our appointment system is now being used to provide a safe and efficient patient journey for COVID-19 testing and vaccinations,” said Jonathan Sudharta, CEO of Halodoc.
Ever since its work with the Indonesian government in 2020, the Indonesian Health Ministry and Gojek have partnered up with Halodoc to run several vaccination centers across the country. Also, only the first 3 weeks saw over 50,000 vaccinations completed, which was a huge success for the company and the government.
As described earlier, Halodoc offers exceptional digital health services to millions of patients across the nation. The company has partnered with more than 20,000 licensed doctors who are just a click away. Patients can book appointments with health professionals and get checked up in an efficient manner.
Halodoc has expanded its services to include pharmacies and medicines and has partnered with over 4,000 drug stores to provide convenient home delivery services with just a click. This service is a recent addition to Halodoc’s offerings. [indonesiabased halodoc 80m temasekasia]
Read more:
IDC yoy 39.9m q1 12.7m Samsung, IDC: Apple Ships 12.7m iPads (Out of 39.9M Global) in Q1 ‘21 (+50% YoY), Samsung on 2nd Spot